- Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.
Kappetein AP, Feldman TE, Mack MJ, et al. Eur Heart J. 2011;32(17):2125-2134.
- Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
Mehilli J, Pache J, Abdel-Wahab M, et al. Lancet. 2011;378(9796):1071-1078. Epub 2011. Erratum in: Lancet. 2012;379(9811):122.
- Saphenous vein graft intervention.
Lee MS, Park SJ, Kandzari DE, et al. JACC Cardiovasc Interv. 2011;4(8):831-843.
- A Randomized Clinical Study Comparing Double Kissing Crush With Provisional Stenting for Treatment of Coronary Bifurcation Lesions Results From the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) Trial.
Chen SL, Santoso T, Zhang JJ, et al. J Am Coll Cardiol. 2011;57(8):914-920.
- Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity.
Kang SJ, Lee JY, Ahn JM, et al. Circ Cardiovasc Interv. 2011;4(1):65-71.
- Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.
Jolly SS, Yusuf S, Cairns J, et al. Lancet. 2011;377(9775):1409-1420. Epub 2011. Erratum in: Lancet. 2011;377(9775):1408. Lancet. 2011;378(9785):30.
- The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention.
Kovacic JC, Nguyen HT, Karajgikar R, et al. Catheter Cardiovasc Interv. 2011. [Epub ahead of print]
- Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.
Bonello L, Tantry US, Marcucci R, et al. J Am Coll Cardiol. 2010;56(12):919-933.
- Lipid-rich obstructive coronary lesions: Is plaque characterization any important?
Fernandez-Friera L, Garcia-Alvarez A, Romero A, et al. JACC Cardiovasc Imaging. 2010;3(8):893-895.
- Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guided.
Nam CW, Yoon HJ, Cho YK, et al. JACC Cardiovasc Interv. 2010;3(8):812-817.
- Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.
Tonino PA, Fearon WF, De Bruyne B, et al. J Am Coll Cardiol. 2010;55(25):2816-2821.
- Perioperative management of patients with drug-eluting stents.
Abualsaud AO, Eisenberg MJ. JACC Cardiovasc Interv. 2010;3(2):131-142. Review.
- Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
Brilakis ES, Wang TY, Rao SV, et al. JACC Cardiovasc Interv. 2010;3(10):1068-1073.
- Coronary embolization following balloon dilation of lipid-core plaques.
Goldstein JA, Grines C, Fischell T, et al. JACC Cardiovasc Imaging. 2009;2(12):1420-1424.
- Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
Mehran R, Lansky AJ, Witzenbichler B, et al. Lancet. 2009;374(9696):1149-1159.
- In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study.
Waxman S, Dixon SR, L'Allier P, et al. JACC Cardiovasc Imaging. 2009;2(7):858-868.
- Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial.
Hamon M, Rasmussen LH, Manoukian SV, et al. EuroIntervention. 2009;5(1):115-120.
- Perspective on bifurcation PCI.
Chen SL, Louvard Y, Runlin G. J Interv Cardiol. 2009;22(2):99-109.
- A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.
Brilakis ES, Lichtenwalter C, de Lemos JA, et al. J Am Coll Cardiol. 2009;53(11):919-928.
- A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.
Serruys PW, Ormiston JA, Onuma Y, et al. Lancet. 2009;373(9667):897-910.
- Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials.
Jolly SS, Amlani S, Hamon M, et al. Am Heart J. 2009;157(1):132-140.
- Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg).
Chase AJ, Fretz EB, Warburton WP, et al. Heart. 2008;94(8):1019-1025.
- Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]).
Kim JS, Moon JY, Ko YG, et al. Am J Cardiol. 2008;102(3):304-310.
- Endothelial cell recovery between comparator polymer-based drug-eluting stents.
Joner M, Nakazawa G, Finn AV, et al. J Am Coll Cardiol. 2008;52(5):333-342.
- Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry.
Rao SV, Ou FS, Wang TY, et al. JACC Cardiovasc Interv. 2008;1(4):379-386.
- Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.
Buszman PE, Kiesz SR, Bochenek A, et al. J Am Coll Cardiol. 2008;51(5):538-545.
- Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.
Buszman PE, Kiesz SR, Bochenek A, et al. J Am Coll Cardiol. 2008;51(5):538-545.
- Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
Vermeersch P, Agostoni P, Verheye S, et al. J Am Coll Cardiol. 2007;50(3):261-267.
- Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.
Daemen J, Wenaweser P, Tsuchida K, et al. Lancet. 2007;369(9562):667-678.
- Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
Eisenstein EL, Anstrom KJ, Kong DF, et al. JAMA. 2007;297(2):159-168.
- Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents.
Pan M, Suárez de Lezo J, Medina A, et al. Am Heart J. 2007;153(1):15.e1-7.
- Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT).
Thuesen L, Kelbaek H, Kløvgaard L, et al. Am Heart J. 2006;152(6):1140-1145.
- Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. J Am Coll Cardiol. 2006;48(12):2584-2591.
- Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
Joner M, Finn AV, Farb A, et al. J Am Coll Cardiol. 2006;48(1):193-202.
- Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
Kotani J, Awata M, Nanto S, et al. J Am Coll Cardiol. 2006;47(10):2108-2111.
- The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos G, Morel MA, Kappetein AP, et al. EuroIntervention. 2005;1(2):219-227.
- Effectiveness of the stent pull-back technique for nonaorto ostial coronary narrowings.
Kini AS, Moreno PR, Steinheimer AM, et al. Am J Cardiol. 2005;96(8):1123-1128.
- Physiologic assessment of jailed side branch lesions using fractional flow reserve.
Koo BK, Kang HJ, Youn TJ, et al. J Am Coll Cardiol. 2005;46(4):633-637.
- Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods.
Moreno PR, Muller JE. Curr Opin Cardiol. 2002;17(6):638-647.
- Provisional bifurcation stenting.
Meerkin D, Almagor Y. Int J Cardiovasc Intervent. 2001;4(2):87-90.
- Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).
Whitlow PL, Bass TA, Kipperman RM, et al. Am J Cardiol. 2001;87(6):699-705.
- Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve.
Briguori C, Anzuini A, Airoldi F, et al. Am J Cardiol. 2001;87(2):136-141.
- Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: the Nordic-Baltic Bifurcation Study III.
Niemelä M, Kervinen K, Erglis A, et al. Circulation. 2011;123(1):79-86.
- New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems.
Abizaid A, Costa JR Jr. Circ Cardiovasc Interv. 2010;3(4):384-393.
- Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
Serruys PW, Silber S, Garg S, et al. N Engl J Med. 2010;363(2):136-146.
- Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.
Hildick-Smith D, de Belder AJ, Cooter N, et al. Circulation. 2010;121(10):1235-1243.
- Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.
Rodés-Cabau J, Bertrand OF, Larose E, et al. Circulation. 2009;120(20):1978-1986.
- Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis.
Hamilos M, Muller O, Cuisset T, et al. Circulation. 2009;120(15):1505-1512.
- Contrast-induced nephropathy and long-term adverse events: cause and effect?
Solomon RJ, Mehran R, Natarajan MK, et al. Clin J Am Soc Nephrol. 2009;4(7):1162-1169.
- Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis.
Park SJ, Kim YH, Park DW, et al. Circ Cardiovasc Interv. 2009;2(3):167-177.
- Unprotected left main intervention: the light at the end of the tunnel?
Stone GW, Mintz GS. Circ Cardiovasc Interv. 2009;2(3):156-158.
- Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
Serruys PW, Morice MC, Kappetein AP, et al. N Engl J Med. 2009;360(10):961-972.
- Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study.
Erglis A, Kumsars I, Niemelä M, et al. Circ Cardiovasc Interv. 2009;2(1):27-34.
- Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
Tonino PA, De Bruyne B, Pijls NH, et al. N Engl J Med. 2009;360(3):213-224.
- Percutaneous Coronary Interventions (PCI) in New York State 2006-2008.
New York State Department of Health.
- The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.
Roy P, Steinberg DH, Sushinsky SJ, et al. Eur Heart J. 2008;29(15):1851-1857.
- Bivalirudin during primary PCI in acute myocardial infarction.
Stone GW, Witzenbichler B, Guagliumi G, et al. N Engl J Med. 2008;358(21):2218-2230.
- Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma.
Sawada T, Shite J, Garcia-Garcia HM, et al. Eur Heart J. 2008;29(9):1136-1146.
- Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Wiviott SD, Trenk D, Frelinger AL, et al. Circulation. 2007;116(25):2923-2932.
- Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ, Natarajan MK, Doucet S, et al. Circulation. 2007;115(25):3189-3196.
- Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Stone GW, Moses JW, Ellis SG, et al. N Engl J Med. 2007;356(10):998-1008.
- Bivalirudin for patients with acute coronary syndromes.
Stone GW, McLaurin BT, Cox DA, et al. N Engl J Med. 2006;355(21):2203-2216.
- Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study.
Steigen TK, Maeng M, Wiseth R, et al. Circulation. 2006;114(18):1955-1961.
- Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.
Spertus JA, Kettelkamp R, Vance C, et al. Circulation. 2006;113(24):2803-2809.
- Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
Iakovou I, Schmidt T, Bonizzoni E, et al. JAMA. 2005;293(17):2126-2130.
- Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
Hochholzer W, Trenk D, Frundi D, et al. Circulation. 2005;111(20):2560-2564.
- Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.
Gurbel PA, Bliden KP, Hiatt BL, et al. Circulation. 2003;107(23):2908-2913.
- Nephrotoxic effects in high-risk patients undergoing angiography.
Aspelin P, Aubry P, Fransson SG, et al. N Engl J Med. 2003 Feb 6;348(6):491-499.
- Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.
Lincoff AM, Bittl JA, Harrington RA, et al. JAMA. 2003;289(7):853-863. Erratum in: JAMA. 2003;289(13):1638.
- Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability.
Moreno PR, Purushothaman KR, Fuster V, et al. Circulation. 2002;105(21):2504-2511.
- Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions.
Abizaid AS, Mintz GS, Mehran R, et al. Circulation. 1999;100(3):256-261.
- A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
Leon MB, Baim DS, Popma JJ, et al. N Engl J Med. 1998;339(23):1665-1671.
- Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro).
Williams MS, Coller BS, Väänänen HJ, et al. Circulation. 1998;98(8):742-748.
- Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure.
Schömig A, Kastrati A, Mudra H, et al. Circulation. 1994;90(6):2716-2724.
- A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
Fischman DL, Leon MB, Baim DS, et al. N Engl J Med. 1994;331(8):496-501.